Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.

Zhang J, Li J, Huang M, Xie X, Cai Y, Hu H, Ling J, Wu Z, Deng Y

Open source

DOI
10.1097/dcr.0000000000002424
Published
2023 Jul 1
Container
Diseases of the colon and rectum
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/dcr.0000000000002424,
  title = {Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.},
  author = {Zhang J and Li J and Huang M and Xie X and Cai Y and Hu H and Ling J and Wu Z and Deng Y},
  year = {2023},
  journal = {Diseases of the colon and rectum},
  doi = {10.1097/dcr.0000000000002424},
  url = {https://doi.org/10.1097/dcr.0000000000002424}
}

RIS

TY  - JOUR
TI  - Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
AU  - Zhang J
AU  - Li J
AU  - Huang M
AU  - Xie X
AU  - Cai Y
AU  - Hu H
AU  - Ling J
AU  - Wu Z
AU  - Deng Y
PY  - 2023
JO  - Diseases of the colon and rectum
DO  - 10.1097/dcr.0000000000002424
UR  - https://doi.org/10.1097/dcr.0000000000002424
ER  - 

APA

J, Z., J, L., M, H., X, X., Y, C., H, H., J, L., Z, W., & Y, D. (2023). Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.. Diseases of the colon and rectum. https://doi.org/10.1097/dcr.0000000000002424

Source records